Gut microbiome differences between metformin- and liraglutide-treated T2DM subjects.

Zhang Wang,Somdutta Saha,Stephanie Van Horn,Elizabeth Thomas,Christopher Traini,Ganesh Sathe,Deepak K Rajpal,James R Brown

Endocrinology, diabetes & metabolism（2018）

引用 56|浏览6

暂无评分

摘要

To our knowledge, this is the first report of GLP-1 agonist-associated changes in the human microbiome and its differentiating effects to metformin. Our study suggests that modulation of the GIT microbiome is a potentially important component in the mechanism of action of these drugs.

查看译文

关键词

liraglutide,metformin,microbiota

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要